Viral pathogenesis in hu-PBL-SCID mice

Seminars in Immunology

Volumn 8, Issue 4, 1996, Pages 255-262

  Mosier, Donald E ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Animal models; EBV; HIV; Viral pathogenesis

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; EPSTEIN BARR VIRUS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; MONONUCLEAR CELL; MOUSE; NONHUMAN; PATHOGENESIS; PERIPHERAL LYMPHOCYTE; PRIMARY INFECTION; REVIEW; SCID MOUSE; VIRUS INFECTION; VIRUS PATHOGENESIS;

EID: 0030220277     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.1996.0032     Document Type: Review

References (87)

1. 1. Mosier DE, Gulizia RJ, Baird SM, Wilson DB (1988) Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature (London) 335:256-259
2. 2. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL (1988) The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 241:1632-1639
3. 3. Kamel-Reid S, Dick JE (1988) Engraftment of immunedeficient mice with human hematopoietic stem cells. Science 242:1706-1709
4. 4. Namikawa R, Kaneshima H, Lieberman M, Weissman IL, McCune JM (1988) Infection of the SCID-hu mouse by HIV-1. Science 242:1684-1686
5. 5. McCune JM, Namikawa R, Lieberman M, Weissman I, Kaneshima H (1990) The SCID-hu mouse as a model system for HIV infection in Human Retroviruses, pp 347-359. Alan R. Liss, Inc., New York, NY
6. 6. Bonyadi M, Rabin L, Salimi S, Brown D, Kosek J, McCune J, Kaneshima H (1993) HIV induces thymus depletion in vivo. Nature 363:728-732
7. 7. Su L, Kaneshima H, Bonyhadi M, Salimi S, Kraft D, Rabin L, McCune J (1995) HIV-1-induced thymocyte depletion is associated with indirect cytopathogenicityand infection of progenitor cells in vivo. Immunity 2:25-36
8. 8. Mosier DE, Gulizia RJ, Baird SM, Wilson DB, Spector DH, Spector SA (1991) Human immunodeficiency virus infection of human-PBL-SCID mice. Science 251:791-794
9. 9. Mosier D, Gulizia R, Maclsaac P, Torbett B, Levy J (1993) Rapid loss of CD4+ T cells in human-PBL-SCID mice by noncytopathic HIV isolates. Science 260:689-692
10. 10. Mosier DE, Gulizia RJ, Baird SM, Spector S, Spector D, Kipps TJ, Fox RI, Carson DA, Cooper N, Richman DD, Wilson DB (1989) Studies of HIV infection and the development of Epstein-Barr virus-related B cell lymphomas following transfer of human lymphocytes to mice with severe combined immunodeficiency, in Current Topics in Microbiology and Immunology pp 195-199. Springer, Berlin-Heidelberg
11. 11. Dick JE, Plfumio F, Lapidot T (1991) Mouse models for human hematopoiesis. Semi-Immunol 3:367-378
12. 12. Kamel-Reid S, Dick JE, Greaves A, Murdoch B, Doedens M, Grunberger T, Thorner P, Freedman MH, Phillips RA, Letarte M (1992) Differential kinetics of engraftment and induction of CD10 on human pre-B leukemia cell lines in immune deficient scid mice. Leukemia 6:8-17
13. 13. Lapidot T, Pflumio F, Doedens M, Murdoch B, Williams DE, Dick JE (1992) Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 255:1137-1141
14. 14. Mosier DE, Gulizia RJ, MacIsaac P, Mathieson BJ, Smith G, Hu SL, Corey L, Greenberg P (1992) Evaluation of gp160 vaccinees in the hu-PBL-SCID mouse model. AIDS Res Hum Retroviruses 8:1387
15. 15. van Kuyk R, Torbett BE, Gulizia RJ, Leath S, Mosier DE, Koenig S (1994) Cloned human CDS+ cytotoxic T lymphocytes protect human peripheral blood leukocyte-severe combined immunodeficient mice from HIV-1 infection by an HLA-unrestricted mechanism. J Immunol 153:4826-4833
16. 16. Parren P, Ditzel H, Gulizia R, Binley J, Barbas CI, Burton D, Mosier D (1995) Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding site. AIDS 9:1-6
17. 17. Safrit JT, Fung MS, Andrews CA, Braun DG, Sun WN, Chang TW, Koup RA (1993) hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal antibody to the principal neutralizing determinant of envelope gp120. Aids 7:15-21
18. 18. Kyoizumi S, Baum CM, Kaneshima H, McCune JM, Yee EJ, Namikawa R (1992) Implantation and maintenance of functional human bone marrow in SCID-hu mice. Blood 79:1704-1711
19. 19. Chen BP, Galy A, Kyoizumi S, Namikawa R, Scarborough J, Webb S, Ford B, Cen DZ, Chen SC (1994) Engraftment of human hematopoietic precursor cells with secondary transfer potential in SCID-hu mice. Blood 84:2497-2505
20. 20. Fraser CC, Kaneshima H, Hansteen G, Kilpatrick M, Hoffman R, Chen BP (1995) Human allogeneic stem cell maintenance and differentiation in a long-term multilineage SCID-hu graft. Blood 86:1680-1693
21. 21. Mosier DE, Picchio GR, Baird SM, Kobayashi R, Kipps TJ (1992) Epstein-Barr virus-induced human B-cell lymphomas in SCID mice reconstituted with human peripheral blood leukocytes. Cancer Res 52:5552s-5553s
22. 22. Picchio GR, Kobayashi R, Kirven M, Baird SM, Kipps TJ, Mosier DE (1992) Heterogeneity among Epstein-Barr virus-seropositive donors in the generation of immunoblastic B-cell lymphomas in SCID mice receiving human peripheral blood leukocyte grafts. Cancer Res 52:2468-2477
23. 23. Rochford R, Mosier D (1994) Immunobiology of Epstein-Barr virus-associated lymphomas. Clin Immunol Immunopath 71:256-259
24. 24. Rochford R, Mosier DE (1995) Differential Epstein-Barr virus gene expression in B-cell subsets recovered from lymphomas in SCID mice after transplantation of human peripheral blood lymphocytes. J Virol 69:150-155
25. 25. Neri A, Barriga F, Inghirami G, Knowles DM, Neequaye J, Magrath IT, Dalla-Favera R (1991) Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome-associated lymphoma. Blood 77:1092-1095
26. 26. McGrath MS, Shiramize B, Meeker TC, Kaplan LD, Herndier B (1991) AIDS-Associated Polyclonal Lymphoma: Identification of a New HIV-Associated Disease Process. J AIDS 4:408-415
27. 27. Torbett BE, Picchio G, Mosier DE ( 1991) hu-PBL-SCID mice: A model for human immune function, AIDS, and lymphomagenesis. Immunol Rev 124:139-164
28. 28. Carlsson R, Martensson C, Kalliomaki S, Ohlin M, Borrebaeck CAK (1992) Human peripheral blood lymphocytes transplanted into SCID mice constitute an in vivo culture system exhibiting several parameters found in a normal humoral immune response and are a source of immunocytes for the production of human monoclonal antibodies. J Immunol 148:1065-1071
29. 29. Lederman S, Yellin MJ, Inghirami G, Lee JJ, Knowles DM, Chess L (1992) Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help. J Immunol 149:3817-3838
30. 30. Tary-Lehmann M, Saxon A (1992) Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood. J Exp Med 175:503-516
31. 31. Tary-Lehmann M, Lehmann PV, Schols D, Roncarolo MG, Saxon A (1994) Anti-SCID mouse reactivity shapes the human CD4+ T cell repertoire in hu-PBL-SCID chimeras. J Exp Med 180:1817-1827
32. 32. Reinhardt B, Torbett BE, Gulizia RJ, Reinhardt PP, Spector SA, Mosier DE (1994) Human immunodeficiency virus type 1 infection of neonatal severe combined immunodeficient mice xenografted with human cord blood cells. AIDS Res Hum Retroviruses 10:131-141
33. 33. Pflumio F, Lapidot T, Murdoch B, Patterson B, Dick JE (1993) Engraftment of human lymphoid cells into newborn SCID mice leads to graft-versus-host disease. Int Immunol 5:1509-1522
34. 34. Alter BJ, Bach FH (1990) Cellular basis of the proliferative response of human T cells to mouse xenoantigens. J Exp Med 171:333-338
35. 35. Lindahl KF, Bach FH (1976) Genetic and cellular aspects of xenogeneic mixed leukocyte culture reaction. J Exp Med 144:305-318
36. 36. Swain SL, Dutton RW, Schwab R, Yamamoto J (1983) Xenogeneic human anti-mouse T cell responses are due to the activity of the same functional T cell subsets responsible for allospecific and major histocompatiblity complex-restricted responses. J Exp Med 157:720-729
37. 37. Hoffmann-Fezer G, Kranz B, Gall C, Thierfelder S (1992) Peritoneal sanctuary for human lymphopoiesis in SCID mice injected with human peripheral blood lymphocytes from Epstein-Barr virus-negative donors. Eur J Immunol 22:3161-3166
38. 38. Gougeon M-L, Lecoeur H, Dulioust A, Enouf M-G, Crouvoisier M, Goujard C, Debord T, Montagnier L (1996) Programmed cell death in peripheral lymphocytes from HIV-infected patients. J Immunol 156:3509-3520
39. 39. Giorgi JV, Detels R (1989) T-cell subset alterations in HIV-infected homosexual men: NIAID multicenter AIDS cohort study. Clin Immunol Immunopathol 52:10-18
40. 40. Mosier D, Sieburg H (1994) Macrophage-tropic HIV: critical for AIDS pathogenesis? Immunol Today 15:332-339
41. 41. Gulizia R, Levy J, Mosier D (1996) The envelope gp120 gene of human immunodeficiency virus type 1 determines the rate of CD4-positive T cell depletion in SCID mice engrafted with human peripheral blood leukocytes. J Virol 70:4184-4187
42. 42. Shioda T, Levy JA, Cheng-Mayer C (1991) Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature 349:167-169
43. 43. Shioda T, Levy JA, Cheng-Mayer C (1992) Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 89:9434-9438
44. 44. Levy JA (1993) Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 57:183-289
45. 45. York-Higgins D, Cheng-Mayer C, Bauer D, Levy J, Dina D (1990) Human immunodeficiency virus type 1 cellular host range, replication and cytopathicity are linked to the envelope region of the viral genome. J Virol 64:4016-4020
46. 46. Kestler H, Ringler D, Mori K, Panicali D, Sehgal P, Daniel M, Desrosiers R (1991) Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651-662
47. 47. Jamieson B, Aldrovandi G, Flanelles V, Jowett J, Gao L, Bloch L, Chen I, Zack J (1994) Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. J Virol 68:3478-3485
48. 48. Zazopoulos E, Haseltine WA (1993) Effect of nef alleles on replication of human immunodeficiency virus type 1. Virology 194:20-27
49. 49. Bandres JC, Ratner L (1994) Human immunodeficiency virus type 1 Nef protein down-regulates transcription factors NF-kappa B and AP-1 in human T cells in vitro after T-cell receptor stimulation. J Virol 68:3243-3249
50. 50. Miller MD, Warmerdam MT, Gaston I, Greene WC, Feinberg MB (1994) The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J Exp Med 179:101-113
51. 51. Li Y, Kappes J, Conway J, Price R, Shaw G, Hahn B (1991) Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective genomes. J Virol 65:3973-3985
52. 52. Collman R, Balliet JW, Gregory SA, Friedman H, Kolson DL, Nathanson N, Srinivasan A (1992) An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J Virol 66:7517-7521
53. 53. Kaneshima H, Su L, Bonyhadi ML, Connor RI, Ho DD, McCune JM (1994) Rapid-high, syncytium-inducing isolates of human immunodeficiency virus type 1 induce cytopathicity in the human thymus of the SCID-hu mouse. J Virol 68:8188-8192
54. 54. Balliet JW, Kolson DL, Eiger G, Kirn FM, McGann KA, Srinivasan A, Collman R (1994) Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: mutational analysis of a primary HIV-1 isolate. Virology 200:623-631
55. 55. Aldrovandi G, Zack J (1996) Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice. J Virol 70:1505-1511
56. 56. Hwang SS, Boyle TJ, LyerlyHK, Cullen B (1991) Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 253:71-74
57. 57. Westervelt P, Trowbridge D, Epstein L, Blumberg B, Li Y, Hahn B, Shaw G, Price R, Ratner L (1992) Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo. J Virol 66:2577-2582
58. 58. Chesebro B, Wehrly K, Nishio J, Ferryman S (1992) Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison to T cell-tropic isolates: definition of critical amino acids involved in cell tropism. J Virol 66:6547-6554
59. 59. Cheng-Mayer C, Shioda T, Levy JA (1991) Host range, replicative, and cytopathic properties of human immunoeficiency virus type 1 are determined by very few amino acid changes in tat and gp120. J Virol 65:6931-6941
60. 60. Dimitrov DS, Willey RL, Sato H, Chang LJ, Blumenthal R Martin MA (1993) Quantitation of human immunodeficiency virus type 1 infection kinetics. J Virol 67:2182-2190
61. 61. Sullivan N, Thali M, Furman C, Ho DD, Sodroski J (1993) Effect of amino acid changes in the V1/ V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody. J Virol 67:3674-3679
62. 62. Sullivan N, Sun Y, Li J, Hofmann W, Sodroski J (1995) Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. J Virol 69:4413-4422
63. 63. Cheng-Mayer C, Seto D, Levy JA (1991) Altered host range of HIV-1 after passage through various human cell types. Virology 181:288-294
64. 64. Wu Z, Kayman SC, Honnen W, Revesz K, Chen H, Vijh-Warrier S, Tilley SA, McKeating J, Shotton C, Pinter A (1995) Characterization of neutralization epitopes in the V2 region of human immunodeficiency virus type 1 gp120: role of glycosylation in the correct folding of the V1/V2 domain. J Virol 69:2271-2278
65. 65. Fenouillet E, Jones IM (1995) The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160. J Gen Virol 76:1509-1514
66. 66. Moore JP, McKeating JA, Huang YX, Ashkenazi A, Ho DD (1992) Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates. J Virol 66:235-243
67. 67. Moore JP, Cao Y, Qing L, Sattentau QJ, Pyati J, Koduri R, Robinson J, Barbas III CF, Burton DR, Ho DD (1995) Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. J Virol 69:101-109
68. 68. Arthur L, Bess J, Jr, Sowder R, II, Benveniste R, Mann D, Chermann J-C, Henderson L (1992) Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 258:1935-1938
69. 69. Mosier D, Gulizia R, Maclsaac P, CoreyL, Greenberg P (1993) Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes for donors vaccinated with vaccinia gp160 and recombinant gp160. Proc Natl Acad Sci USA 90:2443-2447
70. 70. Hu S-L, Kosowshi SG, Dalrymple JM (1986) Expression of AIDS virus envelope gene in recombinant vaccinia viruses. Nature 320:537-540
71. 71. Redfield RR, Birx DL, Ketter N, Tramont E, Polonis V, Davis C, Brundage JF, Smith G, Johnson S, Fowler A, Wierzba T, Shafferman A, Volvovitz F, Oster C, Burke DS (1991) A phase I evaluation of the safety and immunogenicityof vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. N Engl J Med 324:1677-1684
72. 72. Walker CM, Moody DJ, Stites DP, Levy JA (1989) CDS T lymphocyte control of HIV replication in cultured CD4 cells varies among infected individuals. Cell Immunol 119:470-475
73. 73. Levy JA (1991) Viral and cellular factors influencing HIV tropism. Adv Exp Med Biol 300:1-15
74. 74. Mackewicz CE, Ortega HW, Levy JA (1991) CDS+ cell anti-HIV activity correlates with the clinical state of the infected individual. J Clin Invest 87:1462-1466
75. 75. Burton DR, Pyati J, Koduri R, Sharp SJ, Thorn ton GB, Parren PW, Sawyer LS, Hendry RM, Dunlop N, Nara PL, Lamacchia M, Garratty E, Stiehm ER, Bryson YJ, Cao Y, Moore JP, Ho DD, Barbas CF (1994) Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266:1024-1027
76. 76. Roben P, Moore JP, Thali M, Sodroski J, Barbas 3rd CF, Burton DR (1994) Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1. J Virol 68:4821-4828
77. 77. Gauduin MC, Safrit JT, Weir R, Fung MS, Koup RA (1995) Pre-and postexposure protection against human immunodeficiency virus type 1 infection mediated by a monoclonal antibody. J Infect Dis 171:1203-1209
78. 78. Nalesnik MA, Jaffe R, Starzl TE, Demetris AJ, Porter K, Burnham JA, Makowka L, Ho M, Locker J (1988) The pathology of post-transplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 133:173-192
79. 79. Locker J, Nalesnik M (1989) Molecular genetic analysis of lymphoid tumors arising after organ transplantation. Am J Pathol 135:977-987
80. 80. Veronese ML, Veronesi A, D'Andrea E, Del Mistro A, Indraccolo S, Mazza MR, Mion M, Zamarchi R, Menin C, Panozzo M, Amadori A, Chieco-Bianchi L (1992) Lymphoproliferative disease in human peripheral blood mononuclear cell-injected SCID mice. I. T lymphocyte requirement for B cell tumor generation. J Exp Med 176:1763-1767
81. 81. Rochford R, Hobbs MV, Gamier J-L, Cooper NR, Cannon MJ (1993) Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genes. Proc Natl Acad Sci, USA 90:352-356
82. 82. Picchio GR, Cohen JI, Wyatt ER, Mosier DE ( 1993) Enhanced tumorigenicity of an Epstein-Barr virus-transformed lymphoblastoid cell line is associated with a unique 1:18 chromosomal translocation and decreased expression of lymphocyte function associated antigen-la (CD11a). Am J Pathol 143:342-349
83. 83. Thangavelu M, Snyder L, Anastasi J, Le Beau MM, Kirven M, Picchio G, Mosier DE, Rowley JD (1992) Cytogenetic characterization of B-cell lymphomas from severe combined immunodeficiency disease mice given injections of lymphocytes from Epstein-Barr virus-positive donors. Cancer Res 52:4678-4681
84. 84. Menin C, Ometto L, Veronesi A, Montagna M, Coppola V, Veronese ML, Indraccolo S, Bruni L, Corneo B, Amadori A, De Rossi A, Chieco-Bianchi L, D'Andrea E (1995) Dominance of a single Epstein-Barr virus strain in SCID-mouse tumors induced by injection of peripheral blood mononuclear cells from healthy human donors. Virus Res 36:215-231
85. 85. Cohen JI, Picchio GR, Mosier DE (1992) Epstein-Barr virus nuclear protein 2 is a critical determinant for tumor growth in SCID mice and transformation in vitro. J Virol 66:7555-7559
86. 86. Mosier DE, Stell KL, Gulizia RJ, Torbett BE, Gilmore GL ( 1993) Homozygous scid/scid;beige/beige mice have low levels of spontaneous or neonatal T cell-induced B cell generation. J Exp Med 177:191-194
87. 87. Greene WC (1991) The molecular biology of human immunodeficiency virus type 1 infection. N Engl J Med 324:308-317